KraneShares MSCI All China Health Care Index ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KURE and other ETFs, options, and stocks.

About KURE

KURE tracks a market cap-weighted index of large- and mid-cap Chinese stocks in the health care sector. 

Index-Tracked
MSCI China All Shares NR USD
Index-TrackedMSCI China All Shares NR USD
Category
China Region
CategoryChina Region
Number of holdings
52
Number of holdings52
Inception Date
Jan 31, 2018
Inception DateJan 31, 2018

What's in this fund

Sectors

As of October 16, 2025
Healthcare99.19%
Consumer Defensive0.81%

Top 10 Holdings (53.52% of total assets)

As of October 16, 2025
NameSymbol% Assets
BeOne Medicines Ltd Ordinary Shares06160 (XHKG)8.86%
Jiangsu Hengrui Pharmaceuticals Co Ltd Class A600276 (XSHG)7.48%
Innovent Biologics Inc01801 (XHKG)7.06%
WuXi Biologics (Cayman) Inc02269 (XHKG)6.87%
Sino Biopharmaceutical Ltd01177 (XHKG)4.51%
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A300760 (XSHE)4.48%
Wuxi AppTec Co Ltd Class A603259 (XSHG)4.24%
Akeso Inc Ordinary Shares09926 (XHKG)3.63%
3SBio Inc Shs Unitary 144A/Reg S01530 (XHKG)3.32%
CSPC Pharmaceutical Group Ltd01093 (XHKG)3.07%

KURE Key Statistics

AUM
105.31M
AUM105.31M
Price-Earnings ratio
42.48
Price-Earnings ratio42.48
30-Day yield
30-Day yield
Average volume
84.17K
Average volume84.17K
High today
$19.62
High today$19.62
Low today
$19.38
Low today$19.38
Open price
$19.50
Open price$19.50
Volume
11.93K
Volume11.93K
52 Week high
$21.88
52 Week high$21.88
52 Week low
$13.13
52 Week low$13.13
Expense ratio
0.79
Expense ratio0.79

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted.